NASDAQ$ANAB

Anaptysbio Inc · Q3 2022 earnings

Q3 2022 earnings · · Investor relations

Headline financials

Total Revenue

$1.29M

Previous: $20.9M-93.8%
EPS (adj)

-$1.18

Previous: -$0.24-391.7%
Capital Expenditures

-$183K

Previous: -$1.35M+86.5%
Free Cash Flow

-$33.7M

Previous: -$8.02M-320.1%
Net Income

-$33.5M

Previous: -$6.67M-402.6%
Operating Income

-$29.6M

Previous: -$6.76M-338.2%
Gross Profit

$708K

Previous: -$1.33M+153.2%
Cash & Equivalents

$58.5M

Previous: $336M-82.6%
Total Assets

$619M

Previous: $424M+45.8%
Stock-Based Comp

$6.27M

Previous: $4.36M+43.7%

Revenue & EPS history

Anaptysbio · Revenue · Quarterly

$1.29M

Q3 2022-93.8%vs Q3 2021
Beat estimate in 8 of 13 quarters(62%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2022

Historical avgQ3 2022

-1.7%

Avg return

Earnings day

-1.5%

Avg return

5 days after

-2.2%

Avg return

30 days after

51%

20 / 39 earnings

Positive

+15.8%

Q4 2019

Best reaction

-71.3%

Q3 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.7%-7.0%-20.1%
Q4 2025+14.5%+13.0%+9.2%
Q3 2025+3.5%-2.2%+27.7%
Q1 2025+0.9%+2.6%+18.2%
Q4 2024+4.8%+2.1%+15.5%
Q3 2024+11.4%+6.9%+18.7%
Q2 2024-2.1%+0.9%+13.3%
Q1 2024-9.1%-1.9%-9.0%
Q4 2023+5.1%-5.4%-10.6%
Q3 2023+6.0%-0.1%-9.3%
Q2 2023+1.3%+1.6%+6.5%
Q1 2023-9.5%-13.3%-12.9%
Q4 2022-1.4%-5.1%-12.6%
Q3 2022+0.7%+6.5%-3.0%
Q2 2022-6.2%+6.2%+7.0%
Q1 2022-11.6%-10.1%-14.3%
Q4 2021-3.5%-5.4%-14.6%
Q3 2021+8.9%+2.9%-11.2%
Q2 2021-1.0%+0.4%+15.0%
Q1 2021+3.0%+10.5%+0.6%
Q4 2020+8.4%+4.2%-19.9%
Q3 2020-1.5%-0.3%-18.7%
Q2 2020-5.6%-8.4%-14.4%
Q1 2020+0.2%+13.0%+10.3%
Q4 2019+15.8%+21.9%-11.0%
Q3 2019-71.3%-69.6%-61.2%
Q2 2019-1.4%-5.2%-20.5%
Q1 2019-6.8%-0.7%-3.5%
Q4 2018-1.6%-4.4%+1.8%
Q3 2018-16.1%-19.0%-16.5%
Q2 2018+4.6%+6.8%+10.2%
Q1 2018+0.5%+0.6%-18.8%
Q4 2017-6.6%-9.1%-26.6%
Q3 2017+1.3%+2.7%+37.1%
Q2 2016+0.8%-5.2%+46.0%
Q2 2017+0.8%-5.2%+46.0%
Q1 2016-1.1%+0.2%-15.9%
Q4 2016-1.1%+7.4%-12.4%
Q1 2017+2.5%+7.4%-12.4%
Q3 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro